Literature DB >> 25633829

Tumor formation and drug resistance properties of human glioblastoma side population cells.

Dong Chen1.   

Abstract

Accumulating evidence has demonstrated that the presence of a subset of cells in several types of brain tumor, termed brain cancer stem cells, are responsible for tumor recurrence following chemotherapy or radiotherapy. The isolation and characterization of side population (SP) cells in several types of solid tumor using Hoechst dye has become a powerful technique for obtaining cancer stem cells (CSCs). In the present study, cancer stem‑like SP cells were isolated from the human glioblastoma cell line MG‑12 using the Hoechst 33342 dye exclusion technique. Flow cytometric analysis revealed that the cell line MG‑12 contained 3.2% SP cells, which was reduced to 0.5% in the presence of verapamil, an inhibitor of ATPase‑binding cassette (ABC) transporters. Reverse‑transcription quantitative polymerase chain reaction analysis revealed that the isolated SP cells exhibited increased expression of stem cell markers, including Nestin, Notch 1, octamer‑binding transcription factor 4 (Oct‑4), epithelial cell adhesion molecule (EpCAM) and also ABC transporter protein ABCG2. Additionally, using western blot analysis it was demonstrated that SP cells exhibit positivity and have a higher expression of CD133, CD44, EpCAM, Oct‑4 and B‑cell lymphoma 2. Furthermore, it was demonstrated that the isolated SP cells undergo rapid proliferation, have a high propensity to form tumor spheres and also have a high survival rate following treatment with 5‑fluorouracil. Therefore, the present findings suggest that SP cells of the glioblastoma MG‑12 cell line share characteristics of CSCs. Therefore, the increased expression of stem cell markers and ABCG2 protein may interact with each other and be responsible for drug and apoptotic resistance, tumor recurrence and invasion.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25633829     DOI: 10.3892/mmr.2015.3279

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  3 in total

1.  Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma.

Authors:  Serena Cecchetti; Ileana Bortolomai; Renata Ferri; Laura Mercurio; Silvana Canevari; Franca Podo; Silvia Miotti; Egidio Iorio
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240

2.  FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells.

Authors:  Shibnath Ghatak; Vincent C Hascall; Roger R Markwald; Suniti Misra
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

3.  Identification of a panel of genes as a prognostic biomarker for glioblastoma.

Authors:  Fengfei Wang; Zheng Zheng; Jitian Guan; Dan Qi; Shuang Zhou; Xin Shen; Fushun Wang; David Wenkert; Batool Kirmani; Touradj Solouki; Ekokobe Fonkem; Eric T Wong; Jason H Huang; Erxi Wu
Journal:  EBioMedicine       Date:  2018-10-16       Impact factor: 8.143

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.